Halozyme Therapeutics | الدين





الدين تغيير تاريخ
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
Baxter International USD 9.71B 13M 2025-09
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 858.06M 199.93M 2025-06
DBV Technologies USD 8.59M 295K 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
MannKind USD 46.82M 243.3M 2025-06
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 60.85B 78M 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12


Halozyme Therapeutics الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.